Tue, 22 October 2019
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes. |
Tue, 1 October 2019
In this episode, we provide an overview of chronic idiopathic constipation and discuss available treatment options with a particular focus on lubiprostone, linaclotide, plecanatide, and prucalopride. |